MedTrace Logo

Nefazodone in the Treatment of Cocaine Dependence and Depression - 4

NCT00015210 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2015-07-30

No results posted yet for this study

Summary

The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.

Conditions

  • Cocaine-Related Disorders
  • Substance-Related Disorders

Interventions

DRUG

Nefazodone

BEHAVIORAL

Psychosocial Treatment

All subjects attended a weekly 1-hour therapy session during the 8 week treatment period.

Sponsors & Collaborators

  • Boston University

    collaborator OTHER

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Dom Ciraulo, M.D. · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-02-28
Primary Completion
1999-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00015210 on ClinicalTrials.gov